Subscribe for the newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Directory
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Clinical Trials
Filter
Filter
Sort By
Newest First
Sector
Modality / Product
Reset
Sign in
1 / 41
1 / 41
Recruitment
Bringing Clinical Trial Enrollment to the Point of Diagnosis
Tim Rich; Matt Schwartz
PPD, part of Thermo Fisher Scientific
PAO-04-25-CL-01
Apr 28, 2025
Automation
Tailor-Made Automation Solutions for Systems and Complete Process Plants – from Field Level to ERP System
Eckelmann Group
PR-04-25-NI-03
Apr 18, 2025
Trans and Non-Binary
Beyond the Binary: Including Trans and Non-Binary Individuals in Clinical Research
David Alvaro, Ph.D.
Pharma's Almanac
PAO-04-25-NI-05
Apr 10, 2025
Inhalation
Unparalleled Expertise and Transparency Drive a Unique Development, Manufacturing, and Clinical Supply Experience
David Wood
Experic
PAO-03-25-CL-04
Apr 05, 2025
Psychedelics
Unlocking the Potential of Psychedelics for Postpartum Depression
Greg Mayes, J.D.
Reunion Neuroscience
PAO-03-25-CL-05
Mar 31, 2025
Global Trials
Clinical Trials Without Borders: The Evolution of Global Drug Development
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-21
Mar 14, 2025
Advocacy
From Patients to Partners: The Rising Power of Advocacy in Drug Development
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-19
Mar 13, 2025
DCTs
Accelerating Patient Access Through Decentralized Clinical Trials
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-25-30-18
Mar 12, 2025
Dermatitis
Amgen and Kyowa Kirin Provide Top-Line Results From Rocatinlimab Phase 3 IGNITE Study in Atopic Dermatitits
Amgen
PR-03-25-NI-03
Mar 10, 2025
Diversity
Fighting for Diversity and Equity in Pharma and Biopharma
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-05
Mar 06, 2025
Real-World Evidence
Overcoming Challenges and Unlocking the Potential of Real-World Evidence
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-09
Mar 02, 2025
Approval
Anixa Biosciences Announces Approval of Protocol Amendment for Ovarian Cancer CAR-T Clinical Trial
Anixa Biosciences
PR-02-25-NI-16
Feb 19, 2025
Clinical Trials
EXUMA Biotech Announces Phase 1 Results for its Autologous HER2 Directed CAR-T Product at ASCO GI 2025
EXUMA Biotechnology
PR-01-25-NI-26
Feb 11, 2025
Clinical Trials
CARsgen's First Enrolled Subject in the THANK-u Plus™ Platform-Based Allogeneic CAR-T Trial Achieves sCR at Week 4
Carsgen Therapeutics
PR-02-25-NI-09
Feb 11, 2025
Clinical Trials
Caliway Announces CBL-514 Second Phase 2b Study Results (CBL-0205) Met Endpoints
Caliway Biopharmaceuticals
PR-02-25-NI-08
Feb 10, 2025
Announcement
TransCode Therapeutics Announces Completion of Cohort 3 Initial Dosing with Lead Candidate in Phase 1 Clinical Trial
TransCode Therapeutics
PR-02-25-NI-03
Feb 07, 2025
USAID Trials
The Collapse of USAID-Funded Clinical Trials: A Blow to Global Health and Biopharma Innovation
David Alvaro, Ph.D.
Pharma's Almanac
PAO-02-25-NI-02
Feb 06, 2025
Announcement
Avirmax Biopharma Completes First Cohort Enrollment in ABI-110 Gene Therapy Trial for Wet AMD, Including PCV.
Avirmax Biopharma
PR-01-25-NI-31
Feb 04, 2025
Financing
Vetigenics Secures $6 Million Seed Financing, Sees Meaningful Clinical Progress
Vetigenics
PR-01-25-NI-27
Feb 03, 2025
Clinical Trials
Gene Therapeutics (NGGT) Announces Publication of Early Clinical Trial Results for the Treatment of Bietti's Crystalline Dystrophy
NGGT Inc.
PR-01-25-NI-16
Jan 16, 2025
